Skip to main content
DNA Labs India

Oncomine Myelodysplastic Syndrome (MDS) Panel Test

DNA Labs India | ISO 9001:2015 Certified

Oncomine Myelodysplastic Syndrome (MDS) Panel Test

Short Name: MDS Panel Test

Also known as: MDS Genetic Test, Myelodysplastic Syndrome Panel

Oncomine Myelodysplastic Syndrome (MDS) Panel Test test available at DNA Labs India for ₹40,950. Uses Next-Generation Sequencing (NGS) on Whole Blood or Bone Marrow samples. Results in Reports are available by the 15th or 30th of the same month, depending on sample receipt date.. Free home collection in 300+ cities across India.

Genetic PanelAdults🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify genetic mutations in patients suspected of having myelodysplastic syndrome, aiding in confirmation of diagnosis, subtyping MDS, predicting disease progression, and informing targeted treatment strategies.

Test Code
1361
Price
₹40,950
Sample Type
Whole Blood or Bone Marrow
Result Time
Reports are available by the 15th or 30th of the same month, depending on sample receipt date.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Ensure the NGS Test Requisition Form (Form 40) is duly filled. No specific fasting required, but follow any instructions from your healthcare provider.

Method: Venipuncture or bone marrow aspiration

Step 2

Laboratory Analysis

Blood sample will be drawn via venipuncture from a vein in the arm. For bone marrow, aspiration will be performed under local anesthesia by a trained professional.

Step 3

Report Delivery

Apply pressure to the collection site to prevent bleeding. Keep the area clean. Report any unusual symptoms like prolonged bleeding or infection to your doctor.

Timeline: Reports are available by the 15th or 30th of the same month, depending on sample receipt date.

Patient Instructions

1
Before the Test:Complete any required paperwork and inform your doctor about medications or health conditions.
2
During the Test:The sample collection process is quick and typically involves a blood draw or bone marrow aspiration under sterile conditions.
3
After the Test:Resume normal activities unless instructed otherwise. Monitor the collection site for any adverse effects.

About This Test

Who Should Get This Test

The purpose of this test is to identify genetic mutations in patients suspected of having myelodysplastic syndrome, aiding in confirmation of diagnosis, subtyping MDS, predicting disease progression, and informing targeted treatment strategies.

How to Prepare

  • Duly fill NGS Test Requisition Form (Form 40) before sample collection
  • Use a lavender top (EDTA) tube for blood or bone marrow
  • Collect 3 mL of sample (2 mL minimum)
  • Ship sample refrigerated; do not freeze
  • Label the sample correctly with patient details

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This panel provides crucial insights for diagnosing and managing MDS, helping tailor personalized treatment plans based on genetic mutations."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeWhole Blood or Bone Marrow
Sample Volume3 mL (2 mL min.)
Container1 Lavender top (EDTA) tube
Collection MethodVenipuncture or bone marrow aspiration

Sample Stability

Room Temperature
Refrigerator
Frozen
Sample Rejection Criteria:
  • Hemolyzed or clotted sample
  • Incorrect container or tube type
  • Insufficient sample volume
  • Missing or incomplete requisition form

Understanding Your Results

Results indicate the presence or absence of genetic mutations associated with MDS. A 'Detected' result for one or more genes suggests a higher risk or specific subtype of MDS, guiding further management.
📊

Detected

Mutations found; indicates MDS or related disorder. Consult with a hematologist for prognosis and treatment options.

📊

Not Detected

No mutations detected in the tested genes. However, clinical correlation is essential as MDS may have other causes.

⚠️ When to Consult a Doctor:

If you experience symptoms like persistent fatigue, frequent infections, or unexplained bleeding, consult a hematologist or oncologist for evaluation and possible testing.

Limitations

  • May not detect all genetic variants associated with MDS
  • Results should be correlated with clinical findings and other diagnostic tests
  • Limited to known genes in the panel; novel mutations may not be identified

Risks & Considerations

  • Minimal risks from blood draw: bruising, soreness, or rare infection
  • Bone marrow aspiration may involve discomfort or bleeding at the site
  • No significant genetic risks from the test itself

Interfering Factors

  • Sample hemolysis or contamination
  • Incorrect sample storage or transport
  • Insufficient sample volume
  • Use of anticoagulants other than EDTA

Compare With Similar Tests

TestOncomine Myelodysplastic Syndrome (MDS) Panel Test
ComparisonOncomine Myelodysplastic Syndrome (MDS) Panel Test

Frequently Asked Questions

What is the Oncomine MDS Panel Test?
It is a genetic test that analyzes DNA for mutations associated with myelodysplastic syndrome, helping in diagnosis and treatment planning.
Who should consider this test?
Individuals with symptoms of MDS such as fatigue, frequent infections, or bleeding, or those with a family history of blood disorders.
How is the sample collected?
A blood or bone marrow sample is collected in an EDTA tube by a healthcare professional, with home collection available.
Is fasting required for this test?
No, fasting is not required, but a duly filled NGS Test Requisition Form (Form 40) is mandatory.
What does a 'Detected' result mean?
It indicates the presence of genetic mutations linked to MDS, which can help confirm diagnosis and guide treatment.
How long does it take to get results?
Reports are typically delivered by the 15th or 30th of the same month after sample receipt.
Is the test covered by insurance?
Coverage varies; check with your insurance provider. DNA Labs India offers affordable pricing and discounts.
Can the test be done at home?
Yes, free home sample collection is available for online bookings across India.
What genes are included in the panel?
The panel includes genes like ASXL1, DNMT3A, SF3B1, TP53, and others, as well as fusion genes related to MDS.
How accurate is this test?
The test uses next-generation sequencing for high accuracy, but results should be interpreted alongside clinical findings.
Are there any risks associated with the test?
Risks are minimal, typically limited to sample collection side effects like bruising or discomfort.
What should I do after receiving results?
Consult with a hematologist or oncologist to discuss results, prognosis, and potential treatment options.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.